Transcription of chapter 35 Pharmacovigilance - WHO
{{id}} {{{paragraph}}}
Example: barber
chapter 35 Pharmacovigilance - WHO
chapter 35 PharmacovigilanceSummary What is Pharmacovigilance and why is it important? Adverse drug reactions Medication errors Adverse drug Designing a Pharmacovigilance system activities at the facility level Pharmacovigilance activities at the national level Pharmacovigilance activities as part of public health programs Pharmacovigilance activities at the international Data collection data collection Mandatory data collection Active data collection Data collection Data analysis and reporting Taking actions for improvement and further readings guide 35-1 Analysis of medication errors in a hospital.
35 / Pharmacovigilance 35.3 Compared with that in high-income countries, the situ-ation in low-and middle-income countries is likely more urgent because of the poorer state of health system infra-
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
National Prescribing Indicators 2018–2019, National Prescribing Indicators, Focus on Antibiotic Prescribing, National, Applying Performance Indicators to Health, Applying Performance Indicators to Health Systems, Health at a Glance 2013, Health at a Glance 2013 OECD INDICATORS Health at a Glance 2013 OECD INDICATORS, National Audit of Schizophrenia, Indicators, Basic Education Core Curriculum, Health at a Glance 2017